Investigating the effects of immunoglobulin on male infertility
Role of Immunoglobulin in Male Infertility
This study is testing whether giving intravenous immunoglobulin (IVIG) to men with fertility issues can improve their sperm quality and help with assisted reproduction.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 50 (estimated) |
| Sex | Male |
| Sponsor | Salma Kafeel Medical Centre Academic / other |
| Locations | 1 site (Islamabad, Capital) |
| Trial ID | NCT06423989 on ClinicalTrials.gov |
What this trial studies
This study aims to explore the role of intravenous immunoglobulin (IVIG) in treating male subfertility. It will assess the impact of IVIG on semen parameters and the outcomes of assisted reproduction techniques. The approach involves administering IVIG to male patients and monitoring changes in fertility-related metrics. The study seeks to provide insights into the potential benefits of immunotherapy in male infertility cases.
Who should consider this trial
Good fit: Ideal candidates for this study are male patients facing issues with fertility.
Not a fit: Patients who are female or do not have male subfertility issues will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve fertility outcomes for men experiencing subfertility.
How similar studies have performed: There is limited information on similar studies, making this approach relatively novel in the context of male infertility.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * male patients Exclusion Criteria: * female
Where this trial is running
Islamabad, Capital
- Skmc — Islamabad, Capital, Pakistan (Recruiting)
Study contacts
- Study coordinator: DR Riffat, PhD
- Email: rifat.skmc@gmail.com
- Phone: 00923225041390
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.